Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy using HLA mis-matched (3-5/6) related hematopoietic stem cells.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Rizzieri, DA; Koh, LP; Long, GD; Gasparetto, C; Vredenburgh, JJ; Buckley, PJ; Gong, G; Lagoo, A; Davis, P; Lassiter, M; Rooney, B; Niedzwiecki, D; Waters-Pick, B; Burleson, J; Thompson, M; Johns, A; Folz, RJ; Horwtiz, ME; Sullivan, K; Morris, A; Chao, NJ

Published Date

  • November 16, 2003

Published In

Volume / Issue

  • 102 / 11

Start / End Page

  • 482A - 482A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 45th Annual Meeting of the American-Society-of-Hematology

Conference Location


Conference Start Date

  • December 6, 2003

Conference End Date

  • December 9, 2003